Literature DB >> 7648626

Topography and distribution of nerve fibers in the posterior longitudinal ligament of the rat: an immunocytochemical and electron-microscopical study.

M von Düring1, B Fricke, A Dahlmann.   

Abstract

The distribution and immunocytochemical characterization of nerve fibers and their terminals in the posterior longitudinal ligament of the rat lumbar vertebral column was studied in whole-mount preparations and serial semithin and ultrathin sections. Differences in the localization, distribution pattern and density of peptidergic and catecholaminergic nerve fibers were found in the vertebral and intervertebral regions of the posterior longitudinal ligament. For immunocytochemistry, free floating specimens were incubated with primary antibodies against protein gene product 9.5, substance P, calcitonin gene-related peptide, dopamine-beta-hydroxylase, vasoactive intestinal polypeptide and neuropeptide Y together with the avidin-biotin-peroxidase method. In whole-mount preparations, the neural marker protein gene product 9.5 is immunostained in all unmyelinated nerve fibers in the posterior longitudinal ligament, thus giving a panoramic view of the nerve fiber plexus. The most striking nerve fiber plexus is localized in the intervertebral region. In this region, the posterior longitudinal ligament is rich in capillaries that form a dense plexus within its ventral part and extend to the outer layer of the annulus fibrosus. The peptidergic and catecholaminergic innervation of the posterior longitudinal ligament is discussed in the context of pain syndromes related to the vertebral column and degenerative lumbar spine diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648626     DOI: 10.1007/bf00583401

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  34 in total

1.  Innervation of spinal meninges and epidural structures.

Authors:  C J BRIDGE
Journal:  Anat Rec       Date:  1959-03

2.  [Graphic reconstruction for spatial representation of preterminal vessels and intravasal particularities].

Authors:  J STAUBESAND; K H ANDRES
Journal:  Mikroskopie       Date:  1953

Review 3.  Changes in expression of autonomic nerves in aging and disease.

Authors:  G Burnstock
Journal:  J Auton Nerv Syst       Date:  1990-07

4.  Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry.

Authors:  R Uddman; H Hara; L Edvinsson
Journal:  J Auton Nerv Syst       Date:  1989-02

5.  Nerve supply to the posterior longitudinal ligament and the intervertebral disc of the rat vertebral column as studied by acetylcholinesterase histochemistry. II. Regional differences in the distribution of the nerve fibres and their origins.

Authors:  Y Kojima; T Maeda; R Arai; K Shichikawa
Journal:  J Anat       Date:  1990-04       Impact factor: 2.610

6.  Distribution of CGRP-, VIP-, D beta H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat.

Authors:  E L Hill; R Elde
Journal:  Cell Tissue Res       Date:  1991-06       Impact factor: 5.249

Review 7.  Neuropeptides in sensory neurons.

Authors:  S H Buck; J H Walsh; H I Yamamura; T F Burks
Journal:  Life Sci       Date:  1982-05-31       Impact factor: 5.037

8.  Neurogenic inflammation in the rat trachea. I. Changes in venules, leucocytes and epithelial cells.

Authors:  D M McDonald
Journal:  J Neurocytol       Date:  1988-10

9.  Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain.

Authors:  S Markowitz; K Saito; M A Moskowitz
Journal:  J Neurosci       Date:  1987-12       Impact factor: 6.167

10.  Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells.

Authors:  G Ju; T Hökfelt; E Brodin; J Fahrenkrug; J A Fischer; P Frey; R P Elde; J C Brown
Journal:  Cell Tissue Res       Date:  1987-02       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.